U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Monday.
Shares of XPeng Inc. (NYSE:XPEV) rose sharply during Monday's session.
The company delivered 30,895 vehicles last month, marking an increase of 54% year-over-year and 29% from October.
The Guangzhou-based EV startup said that the company’s deliveries of the XPeng Mona M03 hatchback coupe alone exceeded 10,000 units for the third consecutive month since launch. Deliveries of the XPeng P7+ sedan, which the company launched last month, also exceeded 7,000 units.
XPeng shares jumped 6.4% to $12.82 on Monday.
Here are some other big stocks recording gains in today's session.
- NovoCure Limited (NASDAQ:NVCR) shares gained 29.9% to $26.04 after the company announced its Phase 3 PANOVA-Trial met its primary endpoint and demonstrated a statistically significant improvement in its median overall survival rate.
- Super Micro Computer, Inc. (NASDAQ:SMCI) surged 22% to $39.83 after the company announced it completed a review by an independent special committee and stated EY’s conclusions were not supported by findings.
- Fastly, Inc. (NYSE:FSLY) jumped 17% to $9.92.
- Nebius Group N.V. (NASDAQ:NBIS) shares gained 15.5% to $25.40 after the company announced it entered a $700 million private placement financing agreement with institutional investors.
- Enovix Corporation (NASDAQ:ENVX) gained 15.1% to $10.65.
- Zeta Global Holdings Corp. (NYSE:ZETA) jumped 14.6% to $24.41.
- PTC Therapeutics, Inc. (NASDAQ:PTCT) surged 14.3% to $50.15 after the company announced it signed a global licensee and collaboration agreement with Novartis for its PTC518 Huntington’s Disease program.
- Dana Incorporated (NYSE:DAN) gained 14% to $11.39 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $18.
- MINISO Group Holding Limited (NYSE:MNSO) gained 12.9% to $22.60. The company, on Friday, posted first-quarter results.
- Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) climbed 11.3% to $7.87.
- Akso Health Group (NASDAQ:AHG) rose 8.8% to $0.9000.
- Abercrombie & Fitch Co. (NYSE:ANF) gained 8.2% to $161.94.
- Merus N.V. (NASDAQ:MRUS) gained 8% to $48.43 after the company announced it entered into an agreement to exclusively license the right to Ptx the right to commercialize Zenocutuzumab (Zeno) for Nrg1 Fusion-positive cancer in the US.
- The Gap, Inc. (NYSE:GAP) rose 5.7% to $25.63 after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $28 to $30.
Now Read This:
